BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16426923)

  • 1. Splenic small B-cell lymphoma with IGH/BCL3 translocation.
    Soma LA; Gollin SM; Remstein ED; Ketterling RP; Flynn HC; Rajasenan KK; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):218-30. PubMed ID: 16426923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.
    Michaux L; Mecucci C; Stul M; Wlodarska I; Hernandez JM; Meeus P; Michaux JL; Scheiff JM; Noël H; Louwagie A; Criel A; Boogaerts M; Van Orshoven A; Cassiman JJ; Van Den Berghe H
    Genes Chromosomes Cancer; 1996 Jan; 15(1):38-47. PubMed ID: 8824724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
    Huh YO; Abruzzo LV; Rassidakis GZ; Parry-Jones N; Schlette E; Brito-Bapabulle V; Matutes E; Wotherspoon A; Keating MJ; Medeiros LJ; Catovsky D
    Br J Haematol; 2007 Jan; 136(2):220-8. PubMed ID: 17129229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
    McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
    Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia.
    Robinson HM; Taylor KE; Jalali GR; Cheung KL; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2004 Jan; 39(1):88-92. PubMed ID: 14603446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
    Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
    Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas.
    Leich E; Haralambieva E; Zettl A; Chott A; Rüdiger T; Höller S; Müller-Hermelink HK; Ott G; Rosenwald A
    J Pathol; 2007 Sep; 213(1):99-105. PubMed ID: 17582237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.
    Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G
    Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
    Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
    J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia.
    Yabumoto K; Ohno H; Doi S; Edamura S; Arita Y; Akasaka T; Matsumoto J; Kadowaki N; Fukuhara S; Okuma M
    Int J Hematol; 1994 Apr; 59(3):211-8. PubMed ID: 8011990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
    Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
    Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Herry A; Morel F; De Braekeleer M
    Cytogenet Genome Res; 2007; 118(2-4):345-52. PubMed ID: 18000389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology.
    Ruminy P; Jardin F; Picquenot JM; Gaulard P; Parmentier F; Buchonnet G; Maisonneuve C; Tilly H; Bastard C
    Oncogene; 2006 Aug; 25(35):4947-54. PubMed ID: 16619046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations.
    Aamot HV; Bjørnslett M; Delabie J; Heim S
    Br J Haematol; 2005 Sep; 130(6):845-51. PubMed ID: 16156854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
    Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
    Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
    Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.